martes, 1 de noviembre de 2016

Definition of talazoparib - NCI Drug Dictionary - National Cancer Institute

Definition of talazoparib - NCI Drug Dictionary - National Cancer Institute

National Cancer Institute

Terms & Properties
Preferred Name: Talazoparib
Definition: An orally bioavailable inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential antineoplastic activity. Talazoparib selectively binds to PARP and prevents PARP-mediated DNA repair of single strand DNA breaks via the base-excision repair pathway. This enhances the accumulation of DNA strand breaks, promotes genomic instability and eventually leads to apoptosis. PARP catalyzes post-translational ADP-ribosylation of nuclear proteins that signal and recruit other proteins to repair damaged DNA and is activated by single-strand DNA breaks.
Display Name: Talazoparib
Label: Talazoparib
NCI Metathesaurus Link: C2987384  (see NCI Metathesaurus info)
Synonyms & Abbreviations: (see Synonym Details)
BMN-673
BMN 673
Talazoparib
External Source Codes: 
PDQ Closed Trial Search ID694964
PDQ Open Trial Search ID694964 (check for NCI PDQ open clinical trial info)
UMLS CUIC2987384
Other Properties:
NameValue (qualifiers indented underneath)
codeC95733
Contributing_SourceCTRP
Semantic_TypePharmacologic Substance
Additional Concept Data: 
Defined Fully by Roles: No 
URL: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C95733


talazoparib



An orally bioavailable inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential antineoplastic activity. Talazoparib selectively binds to PARP and prevents PARP-mediated DNA repair of single strand DNA breaks via the base-excision repair pathway. This enhances the accumulation of DNA strand breaks, promotes genomic instability and eventually leads to apoptosis. PARP catalyzes post-translational ADP-ribosylation of nuclear proteins that signal and recruit other proteins to repair damaged DNA and is activated by single-strand DNA breaks. Check for active clinical trials using this agent. (NCI Thesaurus)
Code name:BMN 673
BMN-673

No hay comentarios:

Publicar un comentario